The Real Questions, Answered Plainly.

GLP-1 (glucagon-like peptide-1) is a hormone the body makes in response to food. It signals satiety, slows gastric emptying, and supports insulin regulation. GLP-1 receptor-agonist medications amplify those effects, which is why they reduce hunger, comfortably shrink portion sizes, and support weight reduction when used under medical supervision.

The default is an FDA-approved GLP-1 medication — the affiliated physician selects the specific FDA-approved product based on your history and response. A compounded version (typically containing semaglutide or tirzepatide as the active ingredient, prepared by a state-licensed U.S. compounding pharmacy) may be prescribed only when the patient’s chart documents a specific clinical reason — for example, an FDA-approved formulation being unavailable to the patient. Compounded medications are not themselves FDA-approved products.

Yes, when clinically appropriate. Testosterone is a Schedule III controlled substance under the Federal Controlled Substances Act; prescribing decisions are made by an affiliated DEA-registered physician based on individual evaluation and current laboratory results. FDA-approved testosterone products are the default prescribing option; a compounded version is only prescribed when the chart documents a specific clinical reason.

Yes, when clinically appropriate. Bioidentical hormone therapy for women (estradiol, progesterone, and, where indicated, testosterone for women off-label) is prescribed by the affiliated physician based on individual evaluation and current laboratory results. The default prescribing option is an FDA-approved bioidentical product where available; a compounded version is only prescribed when the chart documents a specific clinical reason.

For GLP-1: the most common are gastrointestinal — mild nausea, occasional reflux, slower digestion — most likely in the first one to two weeks as the body adjusts to the starting dose. For hormone therapy: side effects depend on the specific medication and dose; the physician reviews these at the protocol consult. Your physician is reachable through the program (per the Care Policy posted on the patient portal) if anything comes up.

$189 per month, all-inclusive. Initial consult, labs, GLP-1 medication when prescribed, TRT or BHRT when prescribed, direct physician messaging — all covered by the monthly rate.

No. The program is cash-pay by design. GLP-1 medications for weight management are generally not covered without a qualifying diagnosis (such as type 2 diabetes); hormone therapy may or may not be covered depending on your plan. Itemized receipts are available on request for HSA/FSA submission.

See the Refund Policy page for the full text. Summary: if your physician determines you’re not a clinical fit at the protocol consult, the first-month fee is fully refunded. After that, refunds are prorated by what has been delivered — less labs, less consultation rendered, less medication shipped, plus prorated refund of any unshipped medication that was prepaid. Cancel any month with no further charges.

No. The monthly fee covers every piece of medical work disclosed at signup. There is no initial-consult charge on top, no titration fee, no shipping charge, no upsell.